Loneliness and Health Outcomes in the High Need Population
NCT ID: NCT05484258
Last Updated: 2023-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2022-08-15
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Loneliness Epidemic Tailoring Interventions to Reduce Loneliness and Pain
NCT05387447
Reducing Loneliness of Older Adults in Long Term Care Facilities Through Collaborative Augmented Realities
NCT06179225
The Economic Consequences of Loneliness Among the Elderly
NCT04225845
Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness
NCT06006000
Reduce Loneliness in Care Partners of Persons With AD/ADRD
NCT05460494
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Loneliness is seen as a significant independent risk factor for poor health behaviors, physical health problems and psychiatric conditions. Loneliness and isolation are becoming a more recognized entity that contributes to worsening depression.
Investigators aim to compare the of effects of a Social Worker and Physician/APP-led support group intervention on loneliness at 9 months, after up to 3 group visits.
Shared Medical Visits as a form of support Group increase clinician-patient contact time and provide patients with support and prevention of chronic conditions increasing patient empowerment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
On baseline screen, would be screened for depression, alcohol use, and loneliness. Loneliness screen will be checked every 3 months.
No interventions assigned to this group
Group Medical VIsits
For this arm, patients will have three visits of a shared medical visit, wherein a physician/APP will partner with a social worker to give a discussion about topics relevant to the high need population, including managing multiple medications, managing stress, and also palliative care.
Shared Medical Visit
Group visit wherein physician and Social Worker, would be discussing topics relevant to the population.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shared Medical Visit
Group visit wherein physician and Social Worker, would be discussing topics relevant to the population.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HCC Score 3.0 and above
* HCC 2.0 - 3.0 and 2 or more unplanned admissions in last 12 months
* HCC 0.24 - 0.35 + ESRD OR
* Charlson Score \>3, or LACE \>30
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francis Balucan
Medical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FRANCIS S BALUCAN
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
220958
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.